Trials / Recruiting
RecruitingNCT07246161
Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women
Detection of Orally Delivered Probiotic Strains in the Vaginal Microbiome of Healthy Female Adults
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Lallemand Health Solutions · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the present study is to obtain more information on the transit of orally ingested probiotics to the vagina.
Detailed description
Probiotics have emerged as novel supplements to support women's health, demonstrating benefits in maintain vaginal health and promoting recovery from dysbiosis. This includes various oral and vaginal probiotics shown to alleviate symptoms and enhance the reversal of vaginal dysbiosis. Oral delivered probiotic strains suggest their ability to migrate and colonize the vagina to support vaginal health but is not well understood. Therefore, this study will aim to provide additional information on their transit to the vagina.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Probiotic Formula 1 | Includes 2 different probiotic strains differing from other intervention groups. |
| OTHER | Probiotic Formula 2 | Includes 2 different probiotic strains differing from other intervention groups. |
| OTHER | Probiotic Formula 3 | Includes 2 different probiotic strains differing from other intervention groups. |
Timeline
- Start date
- 2025-10-20
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-11-24
- Last updated
- 2025-11-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07246161. Inclusion in this directory is not an endorsement.